- Home
- BCDA vs IVDA Comparison
BCDA vs IVDA Comparison
Compare BCDA & IVDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCDA
- IVDA
- Stock Information
- Founded
- BCDA N/A
- IVDA 2003
- Country
- BCDA United States
- IVDA United States
- Employees
- BCDA N/A
- IVDA N/A
- Industry
- BCDA Biotechnology: Pharmaceutical Preparations
- IVDA Computer Software: Prepackaged Software
- Sector
- BCDA Health Care
- IVDA Technology
- Exchange
- BCDA Nasdaq
- IVDA Nasdaq
- Market Cap
- BCDA 7.9M
- IVDA 3.5M
- IPO Year
- BCDA N/A
- IVDA N/A
- Fundamental
- Price
- BCDA $2.68
- IVDA $1.66
- Analyst Decision
- BCDA Strong Buy
- IVDA
- Analyst Count
- BCDA 1
- IVDA 0
- Target Price
- BCDA $25.00
- IVDA N/A
- AVG Volume (30 Days)
- BCDA 73.1K
- IVDA 39.8K
- Earning Date
- BCDA 11-06-2024
- IVDA 11-20-2024
- Dividend Yield
- BCDA N/A
- IVDA N/A
- EPS Growth
- BCDA N/A
- IVDA N/A
- EPS
- BCDA N/A
- IVDA N/A
- Revenue
- BCDA $428,000.00
- IVDA $3,779,754.00
- Revenue This Year
- BCDA $6.92
- IVDA $23.76
- Revenue Next Year
- BCDA N/A
- IVDA $229.89
- P/E Ratio
- BCDA N/A
- IVDA N/A
- Revenue Growth
- BCDA 0.71
- IVDA N/A
- 52 Week Low
- BCDA $1.96
- IVDA $1.40
- 52 Week High
- BCDA $23.25
- IVDA $10.16
- Technical
- Relative Strength Index (RSI)
- BCDA 49.01
- IVDA 42.70
- Support Level
- BCDA $2.39
- IVDA $1.40
- Resistance Level
- BCDA $2.90
- IVDA $1.62
- Average True Range (ATR)
- BCDA 0.18
- IVDA 0.10
- MACD
- BCDA -0.00
- IVDA 0.06
- Stochastic Oscillator
- BCDA 53.70
- IVDA 83.87
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc is engaged in offering real-time IP video surveillance technologies. The company provides IoT sensors and devices for various applications such as energy management, smart homes, smart buildings, smart communities, and patients and eldercare. Its IvedaAI provides AI functions to IP cameras and network video recorders and video management systems. The group has a business presence in the U.S. and the Republic of China (Taiwan), from which key revenue is derived from the Republic of China (Taiwan).